Urinary levels of monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), and renal injuries in patients with type 2 diabetic nephropathy
Open accessThe DOI matches its Crossref record.
Abstract
We examined the correlation among the levels of urinary monocyte chemoattractant protein‐1 (MCP‐1) and interleukin‐8 (IL‐8), hyperglycemia, and renal injuries in patients with type 2 diabetic nephropathy. The levels of urinary MCP‐1, IL‐8, protein excretion, blood urea nitrogen (BUN), serum creatinine (s‐Cr), glycohemoglobin A1c (HbA1c), and fasting plasma glucose (FPG) were measured in 24 patients with type 2 diabetic nephropathy and 14 healthy adults as controls. Diabetic nephropathy was classified into three stages: stage 1 = normoalbuminuric, stage 2 = microalbuminuric, and stage 3 = macroalbuminuric. All of the patients showed normal ranges in renal function tests. Levels of urinary MCP‐1 in all patients with diabetic nephropathy were significantly higher than those in healthy adults (P < 0.05). The levels of urinary MCP‐1 in patients with diabetic nephropathy increased gradually according to the clinical stage of this disease. In contrast, the levels of urinary IL‐8 in patients with diabetic nephropathy increased in stages 2 and 3. There was a significant correlation between the levels of urinary IL‐8 and those of HbA1c. High glucose may stimulate MCP‐1 and/or IL‐8 production and their excretion into the urine independently of the phases or pathological lesions of this disease. It appears that IL‐8 increased in the early stage of diabetic nephropathy, and MCP‐1 increased in the advanced stage of this disease. It was concluded that measurement of urinary MCP‐1 and IL‐8 may be useful for evaluating the degree of renal injuries in patients with type 2 diabetic nephropathy. J. Clin. Lab. Anal. 16:1–4, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Self-citationMonocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Panee, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.018 · Cited by 402
Monocytes from type 2 diabetic patients have a pro-inflammatory profile
Giulietti, A., van Etten, E., Overbergh, L., Stoffels, K., Bouillon, R., & Mathieu, C. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.007 · Cited by 400
Bruun, J., Verdich, C., Toubro, S., Astrup, A., & Richelsen, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480535 · Cited by 295
Pichler, R., Afkarian, M., Dieter, B. P., & Tuttle, K. R. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00314.2016 · Cited by 295
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Calle, P., & Hotter, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082806 · Cited by 249
“Additionally, urinary MCP-1 is upregulated in inflammatory renal disease and diabetic nephropathy [50].”
BackgroundProgressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
Krolewski, A. S. (2015) · Diabetes Care · doi:10.2337/dc15-0184 · Cited by 220
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Rivero, A., Mora, C., Muros, M., García, J., Herrera, H., & Navarro-González, J. F. (2009) · Clinical Science · doi:10.1042/cs20080394 · Cited by 190
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics
Wolkow, P. P., Niewczas, M. A., Perkins, B., Ficociello, L. H., Lipinski, B., Warram, J. H., & Krolewski, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050556 · Cited by 155
Glyoxalase 1 Modulation in Obesity and Diabetes
Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102
“These responses are also likely to be beneficial in clinical diabetes: IL-8 drives renal inflammation (4,172) and PTGS2 increases angiotensin production, renal cell dysfunction and albuminuria (35).”
Metadata
- Authors
- Tashiro, K., Koyanagi, I., Saitoh, A., Shimizu, A., Shike, T., Ishiguro, C., Koizumi, M., Funabiki, K., Horikoshi, S., Shirato, I., & Tomino, Y.
- Venue
- Journal of Clinical Laboratory Analysis
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 16
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0887-8013 (ISSN-L)
- 1098-2825
- OpenAlex
- W1967463529
- Cited by
- 141
- References
- 0
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.